This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Nec Corporation, Tokyo Medical University, Japan Science and Technology Agency. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Setagaya-ku, JP (2014)
- Tokyo, JP (2010 - 2015)
Company Filing History:
2 out of 36,735 
2 out of 11 
1 out of 1,329 
Years Active: 2010-2015
Title: Yoshinori Kosugi: Innovator in Cancer Research
Introduction
Yoshinori Kosugi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 3 patents, his work focuses on the development of cancer markers and evaluation methods.
Latest Patents
Kosugi's latest patents include a novel cancer marker and a method for evaluating cancer using this marker. The invention provides a means to assess the onset, preclinical stage, clinical stage, or prognosis of cancer in a subject. The cancer marker comprises at least one miRNA selected from hsa-miR-92 and hsa-miR-494, specifically for cancers excluding breast cancer. The evaluation method involves detecting the expression level of this cancer marker in a biological sample collected from a subject.
Career Highlights
Throughout his career, Yoshinori Kosugi has worked with notable organizations such as NEC Corporation and Tokyo Medical University. His experience in these institutions has contributed to his expertise in cancer research and innovation.
Collaborations
Kosugi has collaborated with esteemed colleagues, including Masahiko Kuroda and Kosuke Oikawa. These partnerships have further enhanced his research and development efforts in the field of cancer evaluation.
Conclusion
Yoshinori Kosugi's contributions to cancer research through his innovative patents highlight his dedication to improving cancer evaluation methods. His work continues to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile